← FDA DRUG APPROVALS

FDA ANDA · ANDA090128

FAMCICLOVIR

Sponsor: HIKMA

APPLICATION
ANDA090128
TYPE
ANDA
ORIGINAL APPROVAL
2011-03-21
LATEST ACTION
2019-07-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FAMCICLOVIRDiscontinued
FAMCICLOVIR 250MG · TABLET · ORAL
FAMCICLOVIRDiscontinued
FAMCICLOVIR 500MG · TABLET · ORAL
FAMCICLOVIRDiscontinued
FAMCICLOVIR 125MG · TABLET · ORAL

Approval history

2019-07-25Labeling · Supplement 4 · standardAP
2019-07-25Labeling · Supplement 5 · standardAP
2016-03-25Labeling · Supplement 3 · standardAP
2013-04-23Labeling · Supplement 2 · standardAP
2011-08-02Labeling · Supplement 1AP
2011-03-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →